MIRA Pharmaceuticals (MIRA) Competitors $1.32 +0.01 (+0.76%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$2.54 +1.22 (+92.20%) As of 07:31 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA vs. ANEB, WHWK, IFRX, ADAG, PLRX, CRDL, IMUX, STTK, LITS, and ALXOShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Anebulo Pharmaceuticals (ANEB), Whitehawk Therapeutics (WHWK), InflaRx (IFRX), Adagene (ADAG), Pliant Therapeutics (PLRX), Cardiol Therapeutics (CRDL), Immunic (IMUX), Shattuck Labs (STTK), Lite Strategy (LITS), and ALX Oncology (ALXO). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Its Competitors Anebulo Pharmaceuticals Whitehawk Therapeutics InflaRx Adagene Pliant Therapeutics Cardiol Therapeutics Immunic Shattuck Labs Lite Strategy ALX Oncology Anebulo Pharmaceuticals (NASDAQ:ANEB) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Which has more risk and volatility, ANEB or MIRA? Anebulo Pharmaceuticals has a beta of -0.89, indicating that its stock price is 189% less volatile than the S&P 500. Comparatively, MIRA Pharmaceuticals has a beta of 1.69, indicating that its stock price is 69% more volatile than the S&P 500. Do analysts rate ANEB or MIRA? Anebulo Pharmaceuticals currently has a consensus target price of $5.50, indicating a potential upside of 102.21%. Given Anebulo Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts clearly believe Anebulo Pharmaceuticals is more favorable than MIRA Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anebulo Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00MIRA Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals & insiders have more ownership in ANEB or MIRA? 28.4% of Anebulo Pharmaceuticals shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 80.6% of Anebulo Pharmaceuticals shares are held by company insiders. Comparatively, 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, ANEB or MIRA? Anebulo Pharmaceuticals is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnebulo PharmaceuticalsN/AN/A-$8.48M-$0.26-10.46MIRA PharmaceuticalsN/AN/A-$7.85M-$0.49-2.69 Is ANEB or MIRA more profitable? Anebulo Pharmaceuticals' return on equity of -80.85% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Anebulo PharmaceuticalsN/A -80.85% -76.33% MIRA Pharmaceuticals N/A -406.70%-328.44% Does the media prefer ANEB or MIRA? In the previous week, MIRA Pharmaceuticals had 2 more articles in the media than Anebulo Pharmaceuticals. MarketBeat recorded 3 mentions for MIRA Pharmaceuticals and 1 mentions for Anebulo Pharmaceuticals. Anebulo Pharmaceuticals' average media sentiment score of 0.83 beat MIRA Pharmaceuticals' score of 0.34 indicating that Anebulo Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Anebulo Pharmaceuticals Positive MIRA Pharmaceuticals Neutral SummaryAnebulo Pharmaceuticals beats MIRA Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MIRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.98M$3.36B$6.12B$10.45BDividend YieldN/A2.30%5.73%4.77%P/E Ratio-2.6922.7785.3327.36Price / SalesN/A486.46601.99136.95Price / CashN/A46.7037.4661.86Price / Book10.1510.5512.566.81Net Income-$7.85M-$52.58M$3.32B$276.80M7 Day Performance-1.49%0.09%0.59%0.42%1 Month Performance0.76%15.61%10.52%7.86%1 Year Performance20.00%15.13%75.05%41.24% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals0.9139 of 5 stars$1.32+0.8%N/A+25.7%$24.98MN/A-2.692News CoverageHigh Trading VolumeANEBAnebulo Pharmaceuticals2.9878 of 5 stars$2.32flat$5.50+137.1%+43.2%$95.32MN/A-8.924Gap UpWHWKWhitehawk Therapeutics1.0337 of 5 stars$2.04+1.0%N/AN/A$95.20M$25.98M-34.0021IFRXInflaRx2.3887 of 5 stars$1.25-9.4%$6.20+396.0%-15.5%$92.64M$180K-1.5660Positive NewsAnalyst ForecastHigh Trading VolumeADAGAdagene2.5363 of 5 stars$1.91-2.1%$7.00+266.5%-25.1%$91.91M$100K0.00260PLRXPliant Therapeutics4.0997 of 5 stars$1.49+1.4%$8.19+449.5%-88.8%$90.24M$1.58M-0.4490CRDLCardiol Therapeutics2.9791 of 5 stars$1.05+1.0%$8.00+661.9%-43.5%$89.38MN/A-3.0920Positive NewsIMUXImmunic2.252 of 5 stars$0.89-0.4%$9.50+961.9%-44.2%$88.64MN/A-0.9570STTKShattuck Labs3.7959 of 5 stars$1.84flat$3.00+63.0%+18.8%$88.14M$5.72M-1.52100Positive NewsLITSLite StrategyN/A$2.15-13.0%N/AN/A$88.07M$65.30M-0.45100ALXOALX Oncology3.984 of 5 stars$1.85+12.8%$3.30+78.4%+6.4%$87.82MN/A-0.8440Gap Up Related Companies and Tools Related Companies Anebulo Pharmaceuticals Competitors Whitehawk Therapeutics Competitors InflaRx Competitors Adagene Competitors Pliant Therapeutics Competitors Cardiol Therapeutics Competitors Immunic Competitors Shattuck Labs Competitors Lite Strategy Competitors ALX Oncology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MIRA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
